Solid Tumor Cancer Treatment Global Market Report 2024

Description

“Solid Tumor Cancer Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on solid tumor cancer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for solid tumor cancer treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The solid tumor cancer treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Chemotherapy; Targeted Therapy; Immunotherapy; Hormone Therapy; Surgical Procedures
2) By Application: Breast Cancer; Cervical Cancer; Colorectal Cancer; Lung Cancer; Prostate Cancer; Other Applications
3) By End-Users: Hospitals; Research Institutes; Homecare
Companies Mentioned: AstraZeneca plc; Amgen Inc.; B. Braun Melsungen AG; Bristol Myers Squibb & Company; Eli Lilly & Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Solid tumor cancer treatment pertains to addressing abnormal tissue masses that typically lack cysts or liquid regions. These tumors encompass various organs such as the brain, ovary, breast, colon, and others. The proliferation of tumor cells is primarily driven by cancer stem cells undergoing division.

The principal treatments for solid tumor cancer encompass chemotherapy, targeted therapy, immunotherapy, hormone therapy, and surgical interventions. Chemotherapy involves drug-based therapies aimed at halting cell division or eliminating cancer cells to impede their growth. Its applications extend across various cancer types such as breast, cervical, colorectal, lung, prostate, among others. These treatments are utilized across diverse end-users such as hospitals, research institutes, and home care settings.

The solid tumor cancer treatment market research report is one of a series of new reports from The Business Research Company that provides solid tumor cancer treatment market statistics, including solid tumor cancer treatment industry global market size, regional shares, competitors with a solid tumor cancer treatment market share, detailed solid tumor cancer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the solid tumor cancer treatment industry. This solid tumor cancer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The solid tumor cancer treatment market size has grown rapidly in recent years. It will grow from $200.53 billion in 2023 to $230.8 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The historical growth in solid tumor cancer treatment can be attributed to several contributing factors. These include significant advancements in research and development efforts, the successful development and approvals of novel drugs and treatments, a noticeable rise in cancer incidence rates, the increasing population of aging individuals, and the active advocacy efforts and heightened awareness among patients regarding cancer-related issues. These factors collectively propelled the progress and development in the treatment of solid tumor cancers during the historical period.

The solid tumor cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $382.85 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. Anticipated growth in the upcoming period for solid tumor cancer treatment is expected due to several key factors. These include the rising adoption of personalized medicine, significant advancements in immunotherapy, the emergence of global health challenges and new diseases, regulatory frameworks and approvals for novel drugs, and transformations in healthcare financing and reimbursement models. Notable trends predicted for this period encompass further developments in immunotherapy, the expansion of precision medicine and biomarker identification, the use of combination therapies, the integration of digital health solutions, and technological innovations in treatment approaches.

The solid tumor cancer treatment market is anticipated to experience significant growth, primarily driven by the increasing incidence of cancer. Cancer is a severe disorder characterized by the rapid and uncontrolled reproduction of the body's cells, resulting in abnormal growth. Solid tumor cancer treatment involves interventions aimed at removing solid tumors from patients diagnosed with cancer. In 2022, the American Cancer Society reported an estimated increase in new cancer cases from 1,898,160 in 2021 to 1,918,030 in 2022. This escalating incidence of cancer is a key factor propelling the growth of the solid tumor cancer treatment market.

The growth of the solid tumor cancer treatment market is further fueled by the rising global population, particularly the aging population. An aging population, characterized by a higher proportion of elderly individuals within a society, poses unique challenges and complexities related to various types of solid tumors. According to the World Health Organization's projection in October 2022, by 2030, one out of every six individuals globally would be 60 years old or older. The population aged 60 and over is expected to increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion by 2050. The rising aging population is a significant driver of the solid tumor cancer treatment market.

Innovation in products and treatments has emerged as a notable trend in the solid tumor cancer treatment market, with major companies actively focusing on introducing new solutions to sustain their market positions. An illustrative example is Shanghai Henlius Biotech, a China-based biopharmaceutical company, which launched the PD-1 inhibitor HANSIZHUANG in March 2022. HANSIZHUANG, the company's first innovative monoclonal antibody, was developed for treating adults with advanced, unresectable, or metastatic MSI-H (microsatellite instability-high) solid tumors unresponsive to prior conventional treatments. This product innovation not only provides fresh hope for patients with MSI-H solid tumors but also aligns with the demand for precision immunotherapy, fostering the high-quality development of China's biopharmaceutical industry in the solid tumor cancer treatment market.

Prominent companies in the solid tumor cancer treatment market are directing their focus towards the development of monitoring platforms that leverage tailored tests, including personalized assays, for precise detection. Personalized assays involve customized laboratory tests or analytical procedures designed to examine specific characteristics or markers unique to an individual, often based on their genetic or molecular profile. An exemplary illustration is Invitae, a US-based medical genetics company, which, in collaboration with the Tracerx consortium at University College London, launched a personalized cancer monitoring platform in March 2022. This platform is specifically designed for the detection of minimal or molecular residual disease in patients with solid tumors. Utilizing personalized assays based on the patient's tumor, the platform identifies circulating tumor DNA (ctDNA) in the blood. These assays play a crucial role in helping clinicians assess patient risk, gauge treatment response, and predict the likelihood of recurrence.

In March 2021, Takeda Pharmaceutical Company, a leading Japan-based multinational pharmaceutical company, acquired Maverick Therapeutics for $525 million. This acquisition provided Takeda with access to Maverick's T-cell engager COBRA platform and a diverse development portfolio, including TAK-186 (MVC-101) and TAK-280, the latter being the main development candidate (MVC-280). Takeda's acquisition of Maverick Therapeutics enables the expansion of its novel immuno-oncology portfolio, facilitating the advancement of redirected immunotherapies specifically designed to target solid tumors. Maverick Therapeutics Inc., the US-based biotechnology company acquired by Takeda, specializes in providing T-cell targeted immunotherapies for solid tumor cancers. This strategic acquisition positions Takeda to enhance its capabilities in developing innovative solutions for treating solid tumors in the cancer treatment market.

Major companies operating in the solid tumor cancer treatment market report are AstraZeneca plc, Amgen Inc., B. Braun Melsungen AG, Bristol Myers Squibb & Company, Eli Lilly & Company, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Olympus Medical Systems, Astellas Pharma Inc., Celgene Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Ltd., Celldex Therapeutics Inc., AbbVie Inc., Bayer AG, Biogen Inc., Eisai Co. Ltd., Exelixis Inc., Genentech Inc., Gilead Sciences Inc., Incyte Corporation, Ipsen Biopharmaceuticals Inc., Janssen Biotech Inc., Karyopharm Therapeutics Inc., Kyowa Kirin Co. Ltd., MedImmune LLC, Medivation Inc., Millennium Pharmaceuticals Inc., MorphoSys AG, Onyx Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Seattle Genetics Inc., Spectrum Pharmaceuticals Inc., Taiho Pharmaceutical Co. Ltd., Tesaro Inc., Verastem Inc., Zymeworks Inc. .

North America was the largest region in the solid tumor cancer treatment market in 2023. The regions covered in the solid tumor cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the solid tumor cancer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The solid tumor cancer treatment market includes revenues earned by entities by treat solid tumor cancer through hormonal therapy, targeted drugs, and immunotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11350

1. Executive Summary

2. Solid Tumor Cancer Treatment Market Characteristics

3. Solid Tumor Cancer Treatment Market Trends And Strategies

4. Solid Tumor Cancer Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Solid Tumor Cancer Treatment Market Size and Growth

5.1. Global Solid Tumor Cancer Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Solid Tumor Cancer Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Solid Tumor Cancer Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Solid Tumor Cancer Treatment Market Segmentation

6.1. Global Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Chemotherapy
Targeted Therapy
Immunotherapy
Hormone Therapy
Surgical Procedures
6.2. Global Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Breast Cancer
Cervical Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Other Applications
6.3. Global Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Research Institutes
Homecare

7. Solid Tumor Cancer Treatment Market Regional And Country Analysis

7.1. Global Solid Tumor Cancer Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Solid Tumor Cancer Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Solid Tumor Cancer Treatment Market

8.1. Asia-Pacific Solid Tumor Cancer Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Solid Tumor Cancer Treatment Market

9.1. China Solid Tumor Cancer Treatment Market Overview
9.2. China Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Solid Tumor Cancer Treatment Market

10.1. India Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Solid Tumor Cancer Treatment Market

11.1. Japan Solid Tumor Cancer Treatment Market Overview
11.2. Japan Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Solid Tumor Cancer Treatment Market

12.1. Australia Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Solid Tumor Cancer Treatment Market

13.1. Indonesia Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Solid Tumor Cancer Treatment Market

14.1. South Korea Solid Tumor Cancer Treatment Market Overview
14.2. South Korea Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Solid Tumor Cancer Treatment Market

15.1. Western Europe Solid Tumor Cancer Treatment Market Overview
15.2. Western Europe Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Solid Tumor Cancer Treatment Market

16.1. UK Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Solid Tumor Cancer Treatment Market

17.1. Germany Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Solid Tumor Cancer Treatment Market

18.1. France Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Solid Tumor Cancer Treatment Market

19.1. Italy Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Solid Tumor Cancer Treatment Market

20.1. Spain Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Solid Tumor Cancer Treatment Market

21.1. Eastern Europe Solid Tumor Cancer Treatment Market Overview
21.2. Eastern Europe Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Solid Tumor Cancer Treatment Market

22.1. Russia Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Solid Tumor Cancer Treatment Market

23.1. North America Solid Tumor Cancer Treatment Market Overview
23.2. North America Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Solid Tumor Cancer Treatment Market

24.1. USA Solid Tumor Cancer Treatment Market Overview
24.2. USA Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Solid Tumor Cancer Treatment Market

25.1. Canada Solid Tumor Cancer Treatment Market Overview
25.2. Canada Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Solid Tumor Cancer Treatment Market

26.1. South America Solid Tumor Cancer Treatment Market Overview
26.2. South America Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Solid Tumor Cancer Treatment Market

27.1. Brazil Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Solid Tumor Cancer Treatment Market

28.1. Middle East Solid Tumor Cancer Treatment Market Overview
28.2. Middle East Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Solid Tumor Cancer Treatment Market

29.1. Africa Solid Tumor Cancer Treatment Market Overview
29.2. Africa Solid Tumor Cancer Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Solid Tumor Cancer Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Solid Tumor Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Solid Tumor Cancer Treatment Market Competitive Landscape And Company Profiles

30.1. Solid Tumor Cancer Treatment Market Competitive Landscape
30.2. Solid Tumor Cancer Treatment Market Company Profiles
- 30.2.1. AstraZeneca plc
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Amgen Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. B. Braun Melsungen AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Bristol Myers Squibb & Company
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Eli Lilly & Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Solid Tumor Cancer Treatment Market Competitive Benchmarking

32. Global Solid Tumor Cancer Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Solid Tumor Cancer Treatment Market

34. Solid Tumor Cancer Treatment Market Future Outlook and Potential Analysis

34.1 Solid Tumor Cancer Treatment Market In 2028 - Countries Offering Most New Opportunities
34.2 Solid Tumor Cancer Treatment Market In 2028 - Segments Offering Most New Opportunities
34.3 Solid Tumor Cancer Treatment Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer